Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-077434
Filing Date
2022-07-05
Accepted
2022-07-05 17:15:47
Documents
2
Period of Report
2022-07-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2220443-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2220443-1_3seq1.xml 3 1596
2 EXHIBIT 24 tm2220443d1_ex24.htm EX-24 9011
  Complete submission text file 0001104659-22-077434.txt   12058
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Issuer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5150 EL CAMINO REAL, SUITE #A-32 LOS ALTOS CA 94022
Business Address
Jayasuriya Anula (Reporting) CIK: 0001822933 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36714 | Film No.: 221066354